Amgen Inc.

Description

Biotechnology Company
Tagging

Industry: Biotechnology, Pharmaceuticals; Stage: Public; Private / Public: Public (NASDAQ: AMGN); Valuation Basis: Market Cap Dependent; B2B, B2C
Founded

1980
Overview

Develops and manufactures biopharmaceuticals.
Details

Amgen Inc. is a leading biotechnology company that discovers, develops, manufactures, and delivers innovative biopharmaceuticals for a range of serious illnesses, including cancer, heart disease, and inflammatory diseases, improving patient outcomes through scientific advancements.
Workforce Count

20,001-25,000
Views

9

You must log in to view profile.

Quick Links